In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis

Background Uveal melanoma (UM) is the most frequent intraocular malignancy and is resistant to immunotherapy. Nearly 50% of patients with UM develop metastatic disease, and the overall survival outcome remains very poor. Therefore, a treatment regimen that simultaneously targets primary UM and preve...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	In-San Kim, Seohyun Kim, Seong A Kim, Gi-Hoon Nam, Yeonsun Hong, Gi Beom Kim, Yoonjeong Choi, Seokyoung Lee, Yuri Cho, Minsu Kwon, Cherlhyun Jeong, Sehoon Kim
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/a1aee68f0fba46ae9b77ea1f8744cbdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a1aee68f0fba46ae9b77ea1f8744cbdf
record_format	dspace
spelling	oai:doaj.org-article:a1aee68f0fba46ae9b77ea1f8744cbdf2021-11-16T03:30:05ZIn situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis10.1136/jitc-2020-0014812051-1426https://doaj.org/article/a1aee68f0fba46ae9b77ea1f8744cbdf2021-01-01T00:00:00Zhttps://jitc.bmj.com/content/9/1/e001481.fullhttps://doaj.org/toc/2051-1426Background Uveal melanoma (UM) is the most frequent intraocular malignancy and is resistant to immunotherapy. Nearly 50% of patients with UM develop metastatic disease, and the overall survival outcome remains very poor. Therefore, a treatment regimen that simultaneously targets primary UM and prevents metastasis is needed. Here, we suggest an immunotherapeutic strategy for UM involving a combination of local photodynamic therapy (PDT), rho-kinase (ROCK) inhibitor, and PD-1/PD-L1 immune checkpoint blockade.Methods The antitumor efficacy and immune response of monotreatment or combinational treatment were evaluated in B16F10-bearing syngeneic mouse models. Abscopal antitumor immune responses induced by triple-combinational treatment were validated in syngeneic bilateral B16F10 models. After each treatment, the immune profiles and functional examinations were assessed in tumors and tumor draining lymph nodes by flow cytometry, ELISA, and immunofluorescence assays. In orthotopic intraocular melanoma models, the location of the immune infiltrate in the tumor microenvironment (TME) was evaluated after each treatment by multiplex immunohistochemistry and metastatic nodules were monitored.Results PDT with Ce6-embedded nanophotosensitizer (FIC-PDT) elicited immunogenic cell death and stimulated antigen-presenting cells. In situ immunogenic clearance induced by a combination of FIC-PDT with ripasudil, a clinically approved ROCK inhibitor, stimulated antigen-presenting cells, which in turn primed tumor-specific cytotoxic T cells. Moreover, local immunogenic clearance sensitized PD-1/PD-L1 immune checkpoint blockade responses to reconstruct the TME immune phenotypes of cold tumors into hot tumors, resulting in recruitment of robust cytotoxic CD8+ T cells in the TME, propagation of systemic antitumor immunity to mediate abscopal effects, and prolonged survival. In an immune-privileged orthotopic intraocular melanoma model, even low-dose FIC-PDT and ripasudil combined with anti-PD-L1 antibody reduced the primary tumor burden and prevented metastasis.Conclusions A combination of localized FIC-PDT and a ROCK inhibitor exerted a cancer vaccine-like function. Immunogenic clearance led to the trafficking of CD8+ T cells into the primary tumor site and sensitized the immune checkpoint blockade response to evoke systemic antitumor immunity to inhibit metastasis, one of the major challenges in UM therapy. Thus, immunogenic clearance induced by FIC-PDT and ROCK inhibitor combined with anti-PD-L1 antibody could be a potent immunotherapeutic strategy for UM.In-San KimSeohyun KimSeong A KimGi-Hoon NamYeonsun HongGi Beom KimYoonjeong ChoiSeokyoung LeeYuri ChoMinsu KwonCherlhyun JeongSehoon KimBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 In-San Kim Seohyun Kim Seong A Kim Gi-Hoon Nam Yeonsun Hong Gi Beom Kim Yoonjeong Choi Seokyoung Lee Yuri Cho Minsu Kwon Cherlhyun Jeong Sehoon Kim In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
description	Background Uveal melanoma (UM) is the most frequent intraocular malignancy and is resistant to immunotherapy. Nearly 50% of patients with UM develop metastatic disease, and the overall survival outcome remains very poor. Therefore, a treatment regimen that simultaneously targets primary UM and prevents metastasis is needed. Here, we suggest an immunotherapeutic strategy for UM involving a combination of local photodynamic therapy (PDT), rho-kinase (ROCK) inhibitor, and PD-1/PD-L1 immune checkpoint blockade.Methods The antitumor efficacy and immune response of monotreatment or combinational treatment were evaluated in B16F10-bearing syngeneic mouse models. Abscopal antitumor immune responses induced by triple-combinational treatment were validated in syngeneic bilateral B16F10 models. After each treatment, the immune profiles and functional examinations were assessed in tumors and tumor draining lymph nodes by flow cytometry, ELISA, and immunofluorescence assays. In orthotopic intraocular melanoma models, the location of the immune infiltrate in the tumor microenvironment (TME) was evaluated after each treatment by multiplex immunohistochemistry and metastatic nodules were monitored.Results PDT with Ce6-embedded nanophotosensitizer (FIC-PDT) elicited immunogenic cell death and stimulated antigen-presenting cells. In situ immunogenic clearance induced by a combination of FIC-PDT with ripasudil, a clinically approved ROCK inhibitor, stimulated antigen-presenting cells, which in turn primed tumor-specific cytotoxic T cells. Moreover, local immunogenic clearance sensitized PD-1/PD-L1 immune checkpoint blockade responses to reconstruct the TME immune phenotypes of cold tumors into hot tumors, resulting in recruitment of robust cytotoxic CD8+ T cells in the TME, propagation of systemic antitumor immunity to mediate abscopal effects, and prolonged survival. In an immune-privileged orthotopic intraocular melanoma model, even low-dose FIC-PDT and ripasudil combined with anti-PD-L1 antibody reduced the primary tumor burden and prevented metastasis.Conclusions A combination of localized FIC-PDT and a ROCK inhibitor exerted a cancer vaccine-like function. Immunogenic clearance led to the trafficking of CD8+ T cells into the primary tumor site and sensitized the immune checkpoint blockade response to evoke systemic antitumor immunity to inhibit metastasis, one of the major challenges in UM therapy. Thus, immunogenic clearance induced by FIC-PDT and ROCK inhibitor combined with anti-PD-L1 antibody could be a potent immunotherapeutic strategy for UM.
format	article
author	In-San Kim Seohyun Kim Seong A Kim Gi-Hoon Nam Yeonsun Hong Gi Beom Kim Yoonjeong Choi Seokyoung Lee Yuri Cho Minsu Kwon Cherlhyun Jeong Sehoon Kim
author_facet	In-San Kim Seohyun Kim Seong A Kim Gi-Hoon Nam Yeonsun Hong Gi Beom Kim Yoonjeong Choi Seokyoung Lee Yuri Cho Minsu Kwon Cherlhyun Jeong Sehoon Kim
author_sort	In-San Kim
title	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
title_short	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
title_full	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
title_fullStr	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
title_full_unstemmed	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
title_sort	in situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/a1aee68f0fba46ae9b77ea1f8744cbdf
work_keys_str_mv	AT insankim insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT seohyunkim insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT seongakim insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT gihoonnam insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT yeonsunhong insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT gibeomkim insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT yoonjeongchoi insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT seokyounglee insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT yuricho insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT minsukwon insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT cherlhyunjeong insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis AT sehoonkim insituimmunogenicclearanceinducedbyacombinationofphotodynamictherapyandrhokinaseinhibitionsensitizesimmunecheckpointblockaderesponsetoelicitsystemicantitumorimmunityagainstintraocularmelanomaanditsmetastasis
_version_	1718426803621593088

In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis

Ejemplares similares